Scott D. Taylor
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Scott D. Taylor has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Farzad Mirzaei
Department of Chemistry, University of Waterloo, 200 University Avenue West, Waterloo, ON, Canada, and Department of Biochemistry and Molecular Biology, Dalhousie University, Halifax, NS, B3H 1X5, Canada
3 shared publicationsStephen L. Bearne
Department of Chemistry, University of Waterloo, 200 University Avenue West, Waterloo, ON, Canada, and Department of Biochemistry and Molecular Biology, Dalhousie University, Halifax, NS, B3H 1X5, Canada
3 shared publications- Ahmed Magdy Ali
Department of Medicinal Chemistry, Faculty of Pharmacy, Assiut University, Assiut, Egypt
2 shared publications Bryan Hill
Dept. of Chemistry, University of Waterloo, 200 University Ave. West, Waterloo, Ontario, Canada
2 shared publicationsChuda Raj Lohani
Department of Chemistry, University of Waterloo , 200 University Avenue West, Waterloo, Ontario Canada , N2L 3G1
2 shared publicationsLaura J. Ingram
Department of Chemistry, University of Waterloo, 200 University Ave. West, Waterloo, ON N2L 3G1, Canada, Fax: (+1) 519-746-0435
2 shared publications
Latest Publications
- 22 November 2016
- Published by Wiley in ChemBioChem
- Vol. 17 (23) , 2206
Cover Picture: Exploring the Potent Inhibition of CTP Synthase by Gemcitabine-5′-Triphosphate (ChemBioChem 23/2016)
- 22 November 2016
- Published by Wiley in ChemBioChem
- Vol. 17 (23) , 2206
Cover Picture: Exploring the Potent Inhibition of CTP Synthase by Gemcitabine-5′-Triphosphate (ChemBioChem 23/2016)
- 3 March 2016
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 81 (6) , 2624-2628
α-Azido Acids in Solid-Phase Peptide Synthesis: Compatibility with Fmoc Chemistry and an Alternative Approach to the Solid Phase Synthesis of Daptomycin Analogs
α-Azido acids have been used in solid phase peptide synthesis (SPPS) for almost 20 years. Here we report that peptides bearing an N-terminal α-azidoaspartate residue undergo elimination of an azide ion when treated with reagents that are commonly used for removing the Fmoc group during SPPS. We also report an alternative solid-phase route to the synthesis of an analog of daptomycin that uses a reduced number of α-azido amino acids and without elimination of an azide ion.
- 3 March 2016
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 81 (6) , 2624-2628
α-Azido Acids in Solid-Phase Peptide Synthesis: Compatibility with Fmoc Chemistry and an Alternative Approach to the Solid Phase Synthesis of Daptomycin Analogs
α-Azido acids have been used in solid phase peptide synthesis (SPPS) for almost 20 years. Here we report that peptides bearing an N-terminal α-azidoaspartate residue undergo elimination of an azide ion when treated with reagents that are commonly used for removing the Fmoc group during SPPS. We also report an alternative solid-phase route to the synthesis of an analog of daptomycin that uses a reduced number of α-azido amino acids and without elimination of an azide ion.
- 1 December 2015
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 25 (23) , 5490-5494
Solid-phase synthesis and in vitro biological activity of a Thr4→Ser4 analog of daptomycin
- 1 December 2015
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 25 (23) , 5490-5494
Solid-phase synthesis and in vitro biological activity of a Thr4→Ser4 analog of daptomycin
- 1 March 2010
- Published by Wiley in Journal of Peptide Science
- Vol. 16 (4) , 190-199
Synthesis of disulfated peptides corresponding to the N‐terminus of chemokines receptors CXCR6 (CXCR61–20) and DARC (DARC8–42) using a sulfate‐protecting group strategy
Tyrosine sulfation is a post translational modification that occurs on integral membrane and secreted proteins, and is required for mediating crucial biological processes. Until recently the synthesis of sTyr peptides, especially those containing multiple sTyr residues, were among the most challenging peptides to prepare. We recently described an efficient strategy for Fmoc‐based solid phase synthesis of sTyr peptides in which the sulfate group in the sTyr residue(s) is protected with a DCV group (FmocTyr(SO3DCV)OH, 1). After cleavage of the peptide from the support the DCV group is removed by hydrogenolysis. Here we demonstrate that sTyr peptides containing Met or Trp residues can be prepared using our sulfate‐protecting group strategy by preparing peptides corresponding to residues 1–20 of chemokine receptor CXCR6 and 8–42 of chemokine receptor DARC. Removing the DCV groups at the end of the syntheses was readily achieved, without any reduction of the indole ring in Trp, by performing the hydrogenolysis in the presence of triethylamine. These conditions were found to be particularly efficient for removing the DCV group and superiour to our original conditions using H2, ammonium formate, Pd/C. The presence of Met was found not to interfere with the removal of the DCV group. The use of pseudoproline dipeptides and N‐backbone protection with the 2,4‐dimethoxybenzyl group were found to be very effective tactics for preventing aggregation and aspartimide formation during the synthesis of these peptides. We also report an alternative and more cost effective synthesis of amino acid 1. Copyright © 2010 European Peptide Society and John Wiley & Sons, Ltd.
- 1 March 2010
- Published by Wiley in Journal of Peptide Science
- Vol. 16 (4) , 190-199
Synthesis of disulfated peptides corresponding to the N‐terminus of chemokines receptors CXCR6 (CXCR61–20) and DARC (DARC8–42) using a sulfate‐protecting group strategy
Tyrosine sulfation is a post translational modification that occurs on integral membrane and secreted proteins, and is required for mediating crucial biological processes. Until recently the synthesis of sTyr peptides, especially those containing multiple sTyr residues, were among the most challenging peptides to prepare. We recently described an efficient strategy for Fmoc‐based solid phase synthesis of sTyr peptides in which the sulfate group in the sTyr residue(s) is protected with a DCV group (FmocTyr(SO3DCV)OH, 1). After cleavage of the peptide from the support the DCV group is removed by hydrogenolysis. Here we demonstrate that sTyr peptides containing Met or Trp residues can be prepared using our sulfate‐protecting group strategy by preparing peptides corresponding to residues 1–20 of chemokine receptor CXCR6 and 8–42 of chemokine receptor DARC. Removing the DCV groups at the end of the syntheses was readily achieved, without any reduction of the indole ring in Trp, by performing the hydrogenolysis in the presence of triethylamine. These conditions were found to be particularly efficient for removing the DCV group and superiour to our original conditions using H2, ammonium formate, Pd/C. The presence of Met was found not to interfere with the removal of the DCV group. The use of pseudoproline dipeptides and N‐backbone protection with the 2,4‐dimethoxybenzyl group were found to be very effective tactics for preventing aggregation and aspartimide formation during the synthesis of these peptides. We also report an alternative and more cost effective synthesis of amino acid 1. Copyright © 2010 European Peptide Society and John Wiley & Sons, Ltd.
- 9 June 2009
- Published by Wiley in ChemBioChem
- Vol. 10 (9) , 1457-1461
Multiple Pathways for the Irreversible Inhibition of Steroid Sulfatase with Quinone Methide‐Generating Suicide Inhibitors
Unexpected inhibition: 2‐ and 4‐mono‐ and difluoromethyl estrone sulfate derivatives are suicide inhibitors of steroid sulfatase (STS). Kinetic studies suggest that inhibition by the monofluoro derivatives is a result of a quinone methide intermediate that reacts with active‐site nucleophiles, whereas the main inhibition pathway of the 4‐difluoromethyl derivative is a result of decomposition of the initial quinone methide to an aldehyde that acts as potent, almost irreversible inhibitor. magnified image
- 9 June 2009
- Published by Wiley in ChemBioChem
- Vol. 10 (9) , 1457-1461
Multiple Pathways for the Irreversible Inhibition of Steroid Sulfatase with Quinone Methide‐Generating Suicide Inhibitors
Unexpected inhibition: 2‐ and 4‐mono‐ and difluoromethyl estrone sulfate derivatives are suicide inhibitors of steroid sulfatase (STS). Kinetic studies suggest that inhibition by the monofluoro derivatives is a result of a quinone methide intermediate that reacts with active‐site nucleophiles, whereas the main inhibition pathway of the 4‐difluoromethyl derivative is a result of decomposition of the initial quinone methide to an aldehyde that acts as potent, almost irreversible inhibitor. magnified image
- 23 February 2009
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 48 (11) , 2024-2026
Efficient Solid‐Phase Synthesis of Sulfotyrosine Peptides using a Sulfate Protecting‐Group Strategy
Double protection: Efficient Fmoc-based solid-phase synthesis (SPPS) of sulfotyrosine (sY) peptides is achieved by incorporating the sY residue(s) as a dichlorovinyl-protected (DCV) sulfodiester(s) and using 2-methylpiperidine for Fmoc removal. After removal of the other protecting groups, the DCV group could be cleaved by mild hydrogenolysis giving the sY peptides in good yield.
- 23 February 2009
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 48 (11) , 2024-2026
Efficient Solid‐Phase Synthesis of Sulfotyrosine Peptides using a Sulfate Protecting‐Group Strategy
Double protection: Efficient Fmoc-based solid-phase synthesis (SPPS) of sulfotyrosine (sY) peptides is achieved by incorporating the sY residue(s) as a dichlorovinyl-protected (DCV) sulfodiester(s) and using 2-methylpiperidine for Fmoc removal. After removal of the other protecting groups, the DCV group could be cleaved by mild hydrogenolysis giving the sY peptides in good yield.
- 23 February 2009
- Published by Wiley in Angewandte Chemie
- Vol. 121 (11) , 2058-2060
Efficient Solid‐Phase Synthesis of Sulfotyrosine Peptides using a Sulfate Protecting‐Group Strategy
Zweierlei Schutzgruppen: Eine effiziente Fmoc‐Festphasensynthese (Fmoc‐SPPS) von Sulfotyrosin(sY)‐Peptiden gelingt durch Einführen von sY‐Resten als Dichlorvinyl(DCV)‐geschützte Sulfodiester, wobei die Fmoc‐Gruppe mit 2‐Methylpiperidin entfernt wird. Nach Abspaltung der übrigen Schutzgruppen wurden die sY‐Peptide durch milde Hydrogenolyse der DCV‐Gruppe in guten Ausbeuten erhalten. magnified image
- 23 February 2009
- Published by Wiley in Angewandte Chemie
- Vol. 121 (11) , 2058-2060
Efficient Solid‐Phase Synthesis of Sulfotyrosine Peptides using a Sulfate Protecting‐Group Strategy
Zweierlei Schutzgruppen: Eine effiziente Fmoc‐Festphasensynthese (Fmoc‐SPPS) von Sulfotyrosin(sY)‐Peptiden gelingt durch Einführen von sY‐Resten als Dichlorvinyl(DCV)‐geschützte Sulfodiester, wobei die Fmoc‐Gruppe mit 2‐Methylpiperidin entfernt wird. Nach Abspaltung der übrigen Schutzgruppen wurden die sY‐Peptide durch milde Hydrogenolyse der DCV‐Gruppe in guten Ausbeuten erhalten. magnified image
- 8 December 2008
- Published by Wiley in ChemMedChem
- Vol. 3 (12) , 1853-1857
Ground State, Intermediate, and Multivalent Nucleotide Analogue Inhibitors of Cytidine 5′‐Triphosphate Synthase
- 8 December 2008
- Published by Wiley in ChemMedChem
- Vol. 3 (12) , 1853-1857
Ground State, Intermediate, and Multivalent Nucleotide Analogue Inhibitors of Cytidine 5′‐Triphosphate Synthase
- 24 January 2008
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 73 (4) , 1403-1412
Bismethylene Triphosphate Nucleotides of Uridine 4-Phosphate Analogues: A New Class of Anionic Pyrimidine Nucleotide Analogues
Cytidine-5'-triphosphate synthase (CTPS) catalyzes the formation of cytidine triphosphate (CTP) from glutamine, uridine 5'-triphosphate (UTP), and adenosine 5'-triphosphate (ATP). This reaction proceeds via formation of the high-energy intermediate UTP-4-phosphate (UTP-4-P). Stable analogues of UTP-4-P may be potent inhibitors of CTPS and useful as lead structures for the development of anticancer and antiviral agents. Several bismethylene triphosphate (BMT) nucleotides of uridine 4-phosphate (U-4-P) analogues have been prepared. A key step was the selective methanolysis, with the aid of a tin catalyst, of the 5' ester moiety of 2',3',5'-tri-O-acetyl or tri-O-benzoyl U-4-P analogues. We believe this represents the first general approach to the selective cleavage of 5' benzoyl esters in benzoylated nucleosides. Mitsunobu coupling of these 5'-deprotected U-4-P analogues to an unsymmetrical, protected BMT bearing a free phosphonic acid moiety at one of the terminal positions gave fully protected BMT-U-4-P analogues. Global deprotection of these species was achieved using TMSBr followed by treatment with NH4OH-MeOH or NH4OH-pyridine. The resulting BMT nucleotides represent a new class of anionic pyrimidine nucleotide analogues.
- 24 January 2008
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 73 (4) , 1403-1412
Bismethylene Triphosphate Nucleotides of Uridine 4-Phosphate Analogues: A New Class of Anionic Pyrimidine Nucleotide Analogues
Cytidine-5'-triphosphate synthase (CTPS) catalyzes the formation of cytidine triphosphate (CTP) from glutamine, uridine 5'-triphosphate (UTP), and adenosine 5'-triphosphate (ATP). This reaction proceeds via formation of the high-energy intermediate UTP-4-phosphate (UTP-4-P). Stable analogues of UTP-4-P may be potent inhibitors of CTPS and useful as lead structures for the development of anticancer and antiviral agents. Several bismethylene triphosphate (BMT) nucleotides of uridine 4-phosphate (U-4-P) analogues have been prepared. A key step was the selective methanolysis, with the aid of a tin catalyst, of the 5' ester moiety of 2',3',5'-tri-O-acetyl or tri-O-benzoyl U-4-P analogues. We believe this represents the first general approach to the selective cleavage of 5' benzoyl esters in benzoylated nucleosides. Mitsunobu coupling of these 5'-deprotected U-4-P analogues to an unsymmetrical, protected BMT bearing a free phosphonic acid moiety at one of the terminal positions gave fully protected BMT-U-4-P analogues. Global deprotection of these species was achieved using TMSBr followed by treatment with NH4OH-MeOH or NH4OH-pyridine. The resulting BMT nucleotides represent a new class of anionic pyrimidine nucleotide analogues.